Multi-omics reveals a novel Cxcr4⁺ subpopulation of alveolar macrophages and therapeutic effect of AMD3100 in mice with advanced silicosis

Abstract

Background: Silicosis is a work-related condition resulting from breathing in crystalline silica particles, marked by persistent inflammation and abnormal healing mechanisms in the lungs. Our previous studies demonstrated that inhibition of Cxcr4 with Plerixafor (AMD3100) markedly attenuates pulmonary fibrosis.

Methods: By integrating single-cell RNA sequencing with spatial transcriptomics, we analysed lung tissues from a mouse model of pneumoconiosis. Using the Robust Cell Type Decomposition algorithm to deconvolve spatial transcriptomic data, we identified Cxcr4⁺ macrophages and Cxcl12⁺ fibroblasts as central drivers of pulmonary fibrosis progression, revealing a distinct spatial co-localisation pattern between these cell populations. To further delineate macrophage heterogeneity and functional specialisation during silicosis progression, we focused on key macrophage subpopulations.

Results: AMD3100 dynamically remodels the alveolar macrophages (AMs) niche, promoting the restoration of AM homeostasis and significantly reducing both co-expression and spatial co-localisation of Cxcr4/transforming growth factor-β (TGF-β) signalling within macrophages, thereby modulating the fibrotic immune microenvironment. Mechanistically, silica dust stimulation in vitro upregulates Cxcr4 expression in the AM cell line MH-S, which in turn promotes the release of TGF-β and pro-inflammatory factors, driving fibroblast activation. Activated fibroblasts further enhance the pro-fibrotic phenotype of macrophages via secretion of Cxcl12, reinforcing the Cxcr4 signalling axis and establishing a stable positive-feedback loop.

Conclusion: Our findings suggest that silicosis-associated fibrosis progresses through a positive feedback loop involving interactions between Cxcr4⁺ AM macrophages and Cxcl12⁺ fibroblasts. These findings highlight the therapeutic promise of targeting the Cxcl12/Cxcr4 axis with AMD3100 as an innovative approach for silicosis treatment.

Keywords

alveolar macrophages / AMD3100 / multi-omics / silicosis

References

[1] Sherekar P, Suke SG, Dhok A, Malegaonkar S, Dhale SA. Global scenario of silica-associated diseases: a review on emerging pathophysiology of silicosis and potential therapeutic regimes. Toxicol Rep. 2025; 14: 1-13.

[2] Qian Q, Ma Q, Wang B, et al. MicroRNA-205-5p targets E2F1 to promote autophagy and inhibit pulmonary fibrosis in silicosis through impairing SKP2-mediated Beclin1 ubiquitination. Cell Mol Med. 2021; 25(19): 9214-9227.

[3] Feng F, Cheng P, Xu S, et al. Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-beta1/Smad signaling. Chem Biol Interact. 2020; 319: 1-18.

[4] Kulle A, Thanabalasuriar A, Cohen TS, Szydlowska M. Resident macrophages of the lung and liver: the guardians of our tissues. Front Immunol. 2022; 13: 1-21.

[5] Li S, Xu H, Liu S, et al. Targeting Lp-PLA2 inhibits profibrotic monocyte-derived macrophages in silicosis through restoring cardiolipin-mediated mitophagy. Cell Mol Immunol. 2025; 22(7): 776-790.

[6] Lam M, Barry KT, Hodges CJ, et al. NLRP3 deficiency abrogates silica-induced neutrophil infiltration, pulmonary damage and fibrosis. Respir Res. 2025; 26(1): 1-17.

[7] Lv J, Gao H, Ma J, et al. Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis. Front Immunol. 2023; 14: 1-15.

[8] Xu Y, Ying L, Lang JK, Hinz B, Zhao R. Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy. bioRxiv. 2023: 1-13.

[9] Tang PC, Chung JY, Xue VW, et al. Smad3 promotes cancer-associated fibroblasts generation via macrophage-myofibroblast transition. Adv Sci. 2022; 9(1): 1-14.

[10] Wu X, Qian L, Zhao H, et al. CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis. Ageing Res Rev. 2023; 83: 1-11.

[11] Li F, Xu X, Geng J, Wan X, Dai H. The autocrine CXCR4/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity. Exp Ther Med. 2020; 19(3): 1844-1854.

[12] Jaffar J, Griffiths K, Oveissi S, et al. CXCR4+ cells are increased in lung tissue of patients with idiopathic pulmonary fibrosis. Respir Res. 2020; 21(1): 1-16.

[13] Liao K, Yang D, Jin L, et al. Bidirectional mendelian randomization and single-cell sequencing reveal T cell-mediated causal links between COPD and lung adenocarcinoma. Int J Surg. 2025; 111(7): 4528-4538.

[14] Xiao T, Gao D, Gu X, et al. Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-beta signaling pathway and CXCL12/CXCR4 axis. Eur J Pharmacol. 2023; 958: 1-14.

[15] Gabriel Y, Voronov-Goldman M, Solomon B. Reversible inhibition of chemokine receptor CXC4 signaling via AMD3100 mitigates neuroinflammation in Alzheimer's disease. Ageing Neurodegener Dis. 2025; 5(1): 1-8.

[16] Song JS, Kang CM, Kang HH, et al. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis. Exp Mol Med. 2010; 42(6): 465-476.

[17] Sun Q, Tao X, Li B, et al. C‒X‒C-chemokine-receptor-type-4 inhibitor AMD3100 attenuates pulmonary inflammation and fibrosis in silicotic mice. J Inflamm Res. 2022; 15: 5827-5843.

[18] Mu M, Li B, Zou Y, et al. Coal dust exposure triggers heterogeneity of transcriptional profiles in mouse pneumoconiosis and Vitamin D remedies. Part Fibre Toxicol. 2022; 19(1): 1-21.

[19] Cao H, Li B, Mu M, et al. Nicotine suppresses crystalline silica-induced astrocyte activation and neuronal death by inhibiting NF-κB in the mouse hippocampus. CNS Neurosci Ther. 2023; 30(4): 1-18.

[20] Li B, Mu M, Sun Q, et al. A suitable silicosis mouse model was constructed by repeated inhalation of silica dust via nose. Toxicol Lett. 2021; 353: 1-12.

[21] Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013; 14: 1-15.

[22] Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell‒cell communication using CellChat. Nat Commun. 2021; 12(1): 1-20.

[23] Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019; 20(1): 1-15.

[24] Korsunsky I, Millard N, Fan J, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019; 16(12): 1289-1296.

[25] Cable DM, Murray E, Zou LS, et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol. 2022; 40(4): 517-526.

[26] Zhang N, Ma Q, You Y, et al. CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction. Int J Biol Sci. 2022; 18(3): 1271-1287.

[27] Tavakkoli M, Khodashahi R, Aliakbarian M, et al. Review of the role of metabolic factors in determining the post-surgical adhesion and its therapeutic implications, with a focus on extracellular matrix and oxidative stress. Curr Top Med Chem. 2023; 23: 2527-2534.

[28] Seyedpour N, Motevaseli E, Taeb S, et al. Protective effects of alpha-lipoic acid, resveratrol, and apigenin against oxidative damages, histopathological changes, and mortality induced by lung irradiation in rats. Curr Radiopharm. 2024; 17: 99-110.

[29] Xie W-S, Shehzadi K, Ma H-L, Liang J-H. A potential strategy for treatment of neurodegenerative disorders by regulation of adult hippocampal neurogenesis in human brain. Curr Med Chem. 2022; 29(32): 5315-5347.

[30] Timperi E, Gueguen P, Molgora M, et al. Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Cancer Res. 2022; 82(18): 3291-3306.

[31] Sharma M, Kumar U, Singh S. Tumor microenvironment in breast cancer: cellular crosstalk, pathways, and therapeutic insights. Mol Biol Rep. 2025; 53(1): 1-16.

[32] Liu S, Zhang Y, Wan F, et al. The regulatory role of FABP4 in macrophage polarization and lipid accumulation in silicosis. Cell Signal. 2025; 135: 1-13.

[33] Zhang T, Hou Z, Ding Z, Wang P, Pan X, Li X. Single cell RNA-seq identifies cell subpopulations contributing to idiopathic pulmonary fibrosis in humans. Cell Mol Med. 2025; 29(3): 1-12.

[34] Kang H, Gu X, Cao S, Tong Z, Song N. Integrated multi-omics analyses reveal the pro-inflammatory and pro-fibrotic pulmonary macrophage subcluster in silicosis. Ecotoxicol Env Saf. 2024; 284: 1-15.

[35] Vasudevan SO, Behl B, Rathinam VA. Pyroptosis-induced inflammation and tissue damage. Semin Immunol. 2023; 69: 1-8.

[36] Wei Y, You Y, Zhang J, et al. Crystalline silica-induced macrophage pyroptosis interacting with mitophagy contributes to pulmonary fibrosis via modulating mitochondria homeostasis. J Hazard Mater. 2023; 454: 1-15.

[37] Hasegawa Y, Franks JM, Tanaka Y, et al. Pulmonary osteoclast-like cells in silica induced pulmonary fibrosis. Sci Adv. 2024; 10(28): 1-17.

[38] Yuan H, You Y, He Y, et al. Crystalline silica-induced proinflammatory interstitial macrophage recruitment through Notch3 signaling promotes the pathogenesis of silicosis. Environ Sci Technol. 2023; 57(39): 14502-14514.

[39] He Y, Yang F, Yang L, et al. Mechanics-activated fibroblasts promote pulmonary group 2 innate lymphoid cell plasticity propelling silicosis progression. Nat Commun. 2024; 15(1): 1-18.

[40] Zhang Y, Yan J, Ren Y, et al. The role and mechanism of lung microbiota in coal mine dust-induced NLRP3 inflammasome upregulate and lung injury. Sci Rep. 2025; 15(1): 1-12.

[41] Garibaldi BT, D'Alessio FR, Mock JR, et al. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am J Respir Cell Mol Biol. 2013; 48(1): 35-43.

[42] McDowell-Sanchez AK, Cohen ARW, Sanchez S, Tsoyi K. Osteoprotegerin is induced by transforming growth factor-beta 1 and regulates pro-fibrotic responses in human dermal fibroblasts. Biochem Biophys Res Commun. 2025; 754: 1-6.

[43] Yao Y, Hu C, Song Q, et al. ADAMTS16 activates latent TGF-β, accentuating fibrosis and dysfunction of the pressure-overloaded heart. Cardiovasc Res. 2020; 116(5): 956-969.

[44] Arakawa H, Johkoh T, Honma K, et al. Chronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis: its prevalence and comparison of CT findings with idiopathic pulmonary fibrosis. Chest. 2007; 131(6): 1870-1876.

[45] Buechler MB, Fu W, Turley SJ. Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer. Immunity. 2021; 54(5): 903-915.

[46] Kim DH, Kim HC, Im K, et al. Inhibition of AXL ameliorates pulmonary fibrosis via attenuation of M2 macrophage polarisation. Eur Respir J. 2025; 65(6): 1-16.

[47] Yang K, Yang Y, Yu L, et al. Methylation modification is a poor prognostic factor in non-small cell lung cancer and regulates the tumor microenvironment: mRNA molecular structure and function. Int J Biol Macromol. 2024; 282: 1-18.

[48] Ji T, Jiang J, Wang X, Yang K, Wang S, Pan B. Single-cell transcriptomics and machine learning unveil ferroptosis features in tumor-associated macrophages: prognostic model and therapeutic strategies for lung adenocarcinoma. Front Pharmacol. 2025; 16: 1-20.

[49] Yang K, Chen M, Wu Y, et al. Multi-omics integration identifies ASPH and PTTG1 as potential causal drivers of lung adenocarcinoma progression and immune evasion. Front Immunol. 2025; 16: 1-19.

[50] Ji T, Yang X, Chen Y, et al. Prognostic value and biological role of STING-related genes GAB3 and IL16 in lung adenocarcinoma: implications for immune evasion and treatment. Sci Rep. 2025; 16(1): 1-23.

[51] Wu H, Wang Y, Chen T, et al. The N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1. Biosci Rep. 2018; 38(5): 1-19.

[52] Santagata S, Ieranò C, Trotta AM, et al. CXCR4 and CXCR7 signaling pathways: a focus on the cross-talk between cancer cells and tumor microenvironment. Front Oncol. 2021; 11: 1-11.

[53] Lu L, Li J, Jiang X, Bai R. CXCR4/CXCL12 axis: “old” pathway as “novel” target for anti-inflammatory drug discovery. Med Res Rev. 2024; 44(3): 1189-1220.

[54] Su L, Fang M-H, Zou J, et al. Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD. Cell Mol Immunol. 2021; 18(11): 2541-2553.

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.